T2 Biosystems Inc (TTOO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Region:North America

Author(s):

Product Code:GDPH16364D

Download Sample Report download
Buy the Full ReportStarting from $250
Published on

October 2018

Total pages

37

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $250

About the Report

About the Report

Summary

T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company's T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2Plex for research, T2Plex instrument and T2Lyme panels. T2 Biosystems also offers pipeline products for sepsis management, including bacterial resistance panels, and testing for the superbug Candida auris and a Lyme disease panel. The company's products provide species-specific identification directly from whole blood. It offers hemostasis measurements from unpurified clinical samples in hospitals, labs and physicians' offices. T2 Biosystems is headquartered in Lexington, Massachusetts, the US.

T2 Biosystems Inc (TTOO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Products

Products

T2 Biosystems Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Table of Contents

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

T2 Biosystems Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

T2 Biosystems Inc, Medical Devices Deals, 2012 to YTD 2018 9

T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

T2 Biosystems Raises USD 40 Million In Series E Financing 11

Partnerships 13

T2 Biosystems Enters into Agreement with Allergan 13

T2 Biosystems Enters into Co-Development Agreement with Canon U.S. Life Sciences 14

Equity Offering 15

T2 Biosystems Raises USD40 Million in Private Placement of Shares 15

T2 Biosystems Raises USD34 Million in Public Offering of Shares 16

T2 Biosystems Raises USD65.7 Million in IPO 18

T2 Biosystems Inc-Key Competitors 20

T2 Biosystems Inc-Key Employees 21

T2 Biosystems Inc-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Financial Announcements 23

Aug 02, 2018: T2 Biosystems reports second quarter 2018 financial results and provides corporate update 23

May 08, 2018: T2 Biosystems Announces First Quarter 2018 Financial Results 24

Mar 06, 2018: T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and Business Update 25

Nov 02, 2017: T2 Biosystems Reports Third Quarter 2017 Financial Results and Provides Company Update 27

Aug 03, 2017: T2 Biosystems Reports Second Quarter 2017 Financial Results; Provides Company Update 29

May 02, 2017: T2 Biosystems Reports First Quarter 2017 Results and Corporate Update 30

Feb 13, 2017: T2 Biosystems Reports Fourth Quarter and Full-Year 2016 Results 32

Jan 09, 2017: T2 Biosystems Reports Preliminary Fourth Quarter Results and Operational Progress 34

Corporate Communications 35

May 01, 2017: T2 Biosystems Names Darlene Deptula-Hicks as Chief Financial Officer 35

Government and Public Interest 36

Mar 06, 2018: T2 Biosystems Awarded Up To USD 2 Million by CARB-X to Support Development of New Tests on the T2Dx Instrument for Drug-Resistant Bacteria 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List of Figure

List of Figures

T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

T2 Biosystems Inc, Medical Devices Deals, 2012 to YTD 2018 9


List of Table

List of Tables

T2 Biosystems Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

T2 Biosystems Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

T2 Biosystems Inc, Deals By Therapy Area, 2012 to YTD 2018 8

T2 Biosystems Inc, Medical Devices Deals, 2012 to YTD 2018 9

T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

T2 Biosystems Raises USD 40 Million In Series E Financing 11

T2 Biosystems Enters into Agreement with Allergan 13

T2 Biosystems Enters into Co-Development Agreement with Canon U.S. Life Sciences 14

T2 Biosystems Raises USD40 Million in Private Placement of Shares 15

T2 Biosystems Raises USD34 Million in Public Offering of Shares 16

T2 Biosystems Raises USD65.7 Million in IPO 18

T2 Biosystems Inc, Key Competitors 20

T2 Biosystems Inc, Key Employees 21

T2 Biosystems Inc, Other Locations 22

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022